2012 Heart Failure Summit  by unknown
Announcementsedge of the clinically relevant data for valvular heart disease
management.
This inter-disciplinary course emphasizes clinical decision
making while combining the most relevant medical, surgical
and interventional options for patient care. Tools for man-
agement are rapidly advancing and can have significant im-
pacts for the entire care team. Breakout sessions for cardiac
surgeons, cardiologists, nurses, and physician assistants are
designed to involve the specialists in managing their unique
challenges from the team perspective.
Target Audience
This course is intended for cardiothoracic surgeons, cardiol-
ogists, interventional cardiologists, internists, nurses, physi-
cian assistants, and all health care professionals involved in
the evaluation, diagnosis, and/or management of patients
with valvular heart disease.
Accreditation
Physicians
This course has been approved for AMA PRA Category
1 Credits.
Nurses
The American College of Cardiology Foundation is ac-
credited as a provider of continuing nursing education by
the American Nurses Credentialing Center’s Commission
on Accreditation.2012 Heart Failure Summit
21st Century Treatment of Heart Failure: Synchroniz-
ing Surgical and Medical Therapies for Better
Outcomes
October 18–19, 2012
Intercontinental Hotel & Bank of America Conference
Center
Cleveland, OH
The agenda and registration information are available at
www.ccfcme.org/heartfailure12
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Program Overview
TheKaufmanCenter forHeart Failure at ClevelandClinic and
The American Association for Thoracic Surgery have part-290 The Journal of Thoracic and Cardiovascular Surgnered once again to present an educational event for all health
care providers who care for patients with heart failure—21st
Century Treatment of Heart Failure: Synchronizing Surgical
and Medical Therapies for Better Outcomes. Heart failure
is not only a growing and costly problem but also one that
is associated with significant morbidity and mortality. The
increasing prevalence of heart failure is due to the aging
population as well as the marked increase in survival of
patients who suffered from myocardial infarction and
valvular disease.
The current state of management, however, is far from opti-
mal.Moreover, the therapeutic armamentariumhas remained
stagnant since the introduction of resynchronization devices,
with no new therapies in development. Given the undertreat-
ment of heart failure and the lack of new therapies, the focus
of management has shifted to optimizing existing medical
and device therapies, including long-term mechanical circu-
latory support.
Now in its 15th year, this Summit will feature a faculty of
world-renowned cardiologists and cardiovascular sur-
geons who will offer a clinically relevant review and dis-
cussion of current and future therapies for managing heart
failure.
Target Audience
This program is intended for cardiologists, cardiovascular sur-
geons, internists, nurses, physician assistants, perfusionists,
and researchers involved in the management of patients with
heart failure.
Accreditation
The Cleveland Clinic Foundation Center for Continuing
Education is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medi-
cal education for physicians. The Cleveland Clinic Founda-
tion Center for Continuing Education designates this live
activity for a maximum of 14 AMA PRA Category 1
Credits. Physicians should claim only the credit commen-
surate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may
submit the credit hours to the American Osteopathic Associ-
ation for Category 2 credit.
Nurses
For the purposes of recertification and relicensure, The
American Nurses Credentialing Center accepts AMA PRA
Category 1 Credit issued by organizations accredited by
the ACCME.
Abstract Submission
The Heart Failure Summit invites you to submit abstracts
of original investigation for consideration in the Poster
Session on Thursday evening, October 18, from 6:00 PMery c July 2012
Announcementsto 7:30 PM. Abstracts previously presented at other na-
tional or international meetings will be accepted. Ac-
cepted abstracts will be printed in the syllabus. The
deadline for submission is September 21, 2012.
Abstracts must be submitted by E-mail to mavi@jamiebel
kin.com. There is no limit to the number of abstracts a pre-
senter can submit.AATS Focus on Thoracic Surgery: Lung
Cancer
November 16–17, 2012
Boston Marriott Copley Place
Boston, MA
Program Directors
Drs G. Alec Patterson and David J. Sugarbaker, along with
Program Committee members, Drs Thomas D’Amico, Shaf
Keshavjee, James D. Luketich, Bryan Meyers, and Scott J.
Swanson have developed a robust two-day program filled
with invited lectures, case based presentations, videos, and
panel discussions on the following topics:
 CT screening
 Staging
 Navigational Bronchoscopy
 EBUS/EUS
 Video Mediastinoscopy
 VAMLA-TEMLA
 VATS, Robotic and Open Resection
 Lobectomy, Segmentectomy-Wedge and Pneumonec-
tomy
 RFA
 SBRT
 Brachytherapy
 Role of induction Rx and Resection
 Extended Resection
 Guidelines, Efficiency of Care and Database
The complete program can be viewed online at http://aats.
org/LungCancer/program.cgi. Housing and registration
will be available soon.The Journal of Thoracic and CaTarget Audience
Thoracic Surgeons, Pulmonologists, Radiologists, Thoracic
Oncologists, Primary Care Physicians, Residents/Fellows,
Physician Assistants, and Allied Health Professionals.
Lung cancer is the second most common malignancy in the
Western world and the most common cause of cancer-re-
lated death. Recent innovations in diagnosis, staging, and
management of early stage and locally advanced non-small
cell lung cancer have changed the paradigm for surgical
management of lung cancer patients. A virtual explosion
of technological development has enabled widespread use
of minimally invasive approaches that current and future
thoracic surgeons must embrace to improve the care of pa-
tients with lung cancer. The AATS has chosen to highlight
these recent developments in its inaugural ‘‘Focus on Tho-
racic Surgery.’’ The faculty for this program is internation-
ally recognized experts in lung cancer and application of
new technology for its surgical management.
Educational Objectives
 Analyze the current role of endoscopic strategies for
lung cancer diagnosis and staging
 Learn the advantages and limitations of limited resec-
tion for early stage lung cancer
 Appreciate the role of surgical resection in pa-
tients with locally advanced and nodal metastatic
disease
 Identify the various approaches to minimally invasive
pulmonary resection
 Understand the technical challenges and results of ex-
tended pulmonary resection
 Learn the current role of stereotactic body radiotherapy
(SBRT) in the management of early stage non–small
cell lung cancer
The American Association for Thoracic Surgery is ac-
credited by the Accreditation Council for Continuing Med-
ical Education to provide continuing medical education for
physicians. This live activity has been approved for AMA
PRA Category 1 Credits.The Western Thoracic Surgical
Association
Applications for Membership
The WTSA Application for Membership is now online and
must be submitted electronically. A candidate’s application
must include the following uploads: a photo, a complete cur-
riculum vitae with bibliography, and the 3 most significantarticles that s/he personally wrote. The candidates electronic
membership application must be completed and submitted
online by March 1, 2013, and all support letters uploaded
by that candidates sponsors by March 31, 2013, in order
for the candidate to be considered for election to member-
ship at the 2013 Annual Meeting. Visit the WTSA Web
site at www.westernthoracic.org to read membership eligi-
bility requirements and to initiate an online application.rdiovascular Surgery c Volume 144, Number 1 291
